Therefore, positive expression of CD33 and/or CD13 is a certain immunotyping characteristic of B-ALL patients with EP300-ZNF384 fusion, while the lack of CD10 in B-ALL patients may not be a typical phenotype. This evidence concerns the gene EP300 and acute lymphoblastic leukemia.